Lactic acidemia associated with metformin

Annals of Pharmacotherapy

Volumn 37, Issue 1, 2003, Pages 66-69

  Khan, Jamshed K ^a   Pallaki, Muralidhar ^b,c   Tolbert, Sandra R ^b,c,d   Hornick, Thomas R ^b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TOLEDO   (United States)

Author keywords

Lactic acidemia; Metformin

Indexed keywords

LACTIC ACID; METFORMIN;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LACTIC ACIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0037226521     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C183     Document Type: Article

References (16)

1. Johnson AB, Webster JM, Sum CF, Heseltine L, Argyraki M, Cooper BG, et al. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type 2 diabetic patients. Metabolism 1993;42:1217-22.
2. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-9.
3. Schneider J, Erren T, Zofel P, Kaffarnik H. Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus. Atherosclerosis 1990;82:97-103.
4. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: Results of a double blind, placebo-controlled, dose-response trial. Am J Med 1997;103:491-7.
5. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998;21:1659-63.
6. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999;22:925-7.
7. Abbasi AA, Kasmikha R, Sotingeanu DG. Metformin-induced lactic acidemia in patients with type 2 diabetes mellitus. Endocrine Pract 2000;6:442-6.
8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
9. Cohen RD. The metabolic background to acid-base homeostasis and some of its disorders: Lactic acidosis. N Engl J Med 1970;283:978-80.
10. Arieff AI, Park R, Leach WJ, Lazarowitz VC. Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol 1980;239:F135-42.
11. Boyle DI, Evans JM, Sullivan F, Morris AD. Contraindications to metformin therapy in patients with type 2 diabetes - A population-based study of adherence to prescribing guidelines. Diabetic Med 2001;18: 483-8.
12. Sulkin TV. Contraindications to metformin therapy in patients with NTDDM. Diabetes Care 1997;20:925-8.
13. Physicians desk reference. Montvale, NJ: Medical Economics, 2002: 1083.
14. Al-Jebawi AF, Lassman MN, Abourizk NN. Lactic acidosis with therapeutic metformin blood level in a low risk diabetic patient. Diabetes Care 1998;21:1364-5.
15. Lalau JD, Lacroix C, Compagnon P, de Cagny B, Rigaud JP, Chauveau P, et al. Role of metformin accumulation in metformin associated lactic acidosis. Diabetes Care 1995;18:779-84.
16. Lalau JD, Race JM. Lactic acidosis in metformin therapy: Searching for a link with metformin in reports of metformin-associated lactic acidosis. Diabetes Obesity Metab 2001;3:195-201.